StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Patient Presentation with COPD - Essay Example

Cite this document
Summary
Chronic obstructive pulmonary disease, otherwise known as COPD is a general term used in a disease state characterised by progressive limitation and obstruction of the airflow and is associated with chronic cough, dyspnoea on exertion, expectoration and wheezing. …
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER91.4% of users find it useful
Patient Presentation with COPD
Read Text Preview

Extract of sample "Patient Presentation with COPD"

Chronic obstructive pulmonary disease, otherwise known as COPD is a general term used in a disease characterised by progressive limitation and obstruction of the airflow and is associated with chronic cough, dyspnoea on exertion, expectoration and wheezing. COPD is partially irreversible and its symptoms are associated with hyper-responsiveness of the airways. The aforementioned conditions are recognized as a major disability causing a progressive chronic airway obstruction or narrowing that frequently occur as one entity. In the United Kingdom (UK), the prevalence of COPD affects both men and women more commonly in their fourth decade of life. Differential diagnosis of COPD includes asthma, congestive heart failure, bronchiectasis, tuberculosis, obliterative bronchiolitis, and diffuse panbronchiolitis. Nonpharmacological and pharmacological management are considered in treating the patient. Other treatments include rehabilitation, oxygen therapy, and ventilatory support. Patient Presentation with COPD A Brief Introduction: This paper discusses chronic obstructive pulmonary disease (COPD) and its significance in the family and community settings, its socio-economic and cultural background, past medical history, differential diagnosis, and current guidelines relating to pharmacological and nonpharmacological patient management. The analysis of psychosocial impact of COPD to the patient and her family as well as strategies for patient education, and the context of multidisciplinary care team are also will be discussed in the paper. Short Background on COPD: Chronic obstructive pulmonary disease, otherwise known as COPD is a general term used in a disease state characterised by progressive limitation and obstruction of the airflow and is associated with chronic cough, dyspnoea on exertion, expectoration and wheezing (Mannino, 2001; COPD International, 2011; British Medical Journal, 2012; World Health Organization, 2012; and GOLD, 2012). Mannino (2001) stated that COPD is partially irreversible and its symptoms are associated with hyper-responsiveness of the airways. The aforementioned conditions are recognized as a major disability causing a progressive chronic airway obstruction or narrowing that frequently occur as one entity (Patient.co.uk, 2012 and Sharma, 2012). Nursing Assessment: Patient, JC, is a 76 year old female patient with a ten year history of chronic obstructive pulmonary disease (COPD). JC, white female, now 76 years old was 66 year old when diagnosed with COPD in 2002. In the United Kingdom (UK), the prevalence of COPD affects both men and women more commonly in their fourth decade of life (NICE, 2010). It is associated with high rate of mortality and significant healthcare system cost (Raherison and Girodet, 2009). Epidemiological studies note a close association between chronic bronchitis prevalence and low socioeconomic status (Viegi, et al., 2001). COPD is classically thought to be a combination of chronic bronchitis and emphysema, even though in COPD patients, only one of the previously mentioned conditions is present (MayoClinic, 2011; CDC, 2011; and British Medical Journal, 2012). Sharma (2012) defined chronic bronchitis as persistent productive cough for more than three months each year in a period of two consecutive years. The mucous glands in lungs of individuals with chronic bronchitis are enlarged, the airways are inflamed, and the bronchial walls are thickened with subsequent changes and loss of supporting alveolar connection, which results to narrowing and deformity of the lumen of the airway and eventually causes limitation of airflow (Sharma, 2012). On the other hand, emphysema, one of the causative agents of COPD is defined as an abnormal and permanent alveolar enlargement of the terminal bronchioles that results to destruction of the airspace wall (Sharma, 2012). The patient has her own home; she is married with two children and one grandchild. Prior to her diagnosis, the patient worked in an office for most of her working life. She was a known cigarette smoker for 37.5 pack years (Appendix 1). It is generally known that COPD can be caused by smoking, although not exclusively (Patient.co.uk, 2012; GOLD, 2011; and Sharma, 2012). The patient has a dog, which has free run in all areas of her house. She walks the dog twice each day, with no shortness of breath. COPD develops when the airways overreact to irritant present in the air, causing hyper responsiveness of the airway (GOLD, 2011 and Sharma, 2012). Aside from the previous history of smoking, the patient was also exposed to a lung irritant, which is the fur of her pet dog. Past Medical History: December 2, 2004, patient was hospitalised due to worsening shortness of breath and productive cough unresponsive to amoxicillin and prednisolone treatment. On admission, clinical examination revealed widespread wheezing on both lung fields, reported oxygen saturation of 89%, noted to be hypoxic, and treated with nebulisers, doxycycline, and prednisone. Following treatment, she settled rapidly and was discharged. Follow up was in the chest clinic, sputum investigation revealed presence of Moraxella organism. According to Barreirro, et al., (1992), Moraxella catarrhalis is an “aerobic Gram-negative diplococcus which has been regarded traditionally as a commensal organism in the oropharynx.” Recently, it was identified as a pathogen of infections in the bronchopulmonary area (Barreirro, et al., 1992). Arterial blood gases (ABG) obtained from the patient revealed type 1 respiratory failure with pO2 of only 8.95. Arterial Blood Gases, ABG, is a test used to measure the acidity and oxygen and carbon dioxide “in the blood from an artery” (WebMD, 2010). This test is used to “check how well your lungs are able to move oxygen into the blood and remove carbon dioxide from the blood” (WebMD, 2010). Patient subsequently was diagnosed with COPD, moderate airflow obstruction, and ex-smoker. Medication on discharge were Tiotropion 1 puff OD, seretide 500mg 1 puff BID, and ventolin on as needed basis. At her next review in the clinic she was reported to have some reversibility to salbutamol on pulmonary function tests performed at the time. She has a good exercise tolerance as exemplified by her ability to walk her dog twice daily with no apparent complaints of shortness of breathing. It was reported that patient was settled on her medication to date. December 15, 2005, spirometry results (Appendix 3 and 4) were better than the previous year with an FEV1 of 1.47 and FVC of 2.54 and an FEV1/FVC ratio of 58%. In October 2004, her baseline FEV1 was 1.37 and FVC was 3.03 and the FEV1/FVC ratio was 45%. Her predicted levels are FEV1 of 1.88 and FVC of 2.2.7. The improvement in lung function is supported by her clinical condition, she is maintaining a good exercise tolerance, although walks slightly slower than she did previously. There is improvement in her sleeping habit, she can sleep through at night and is not disturbed with breathlessness. There were instances of disturbed sleep pattern, when she had bouts of viral infection, but in general, the patient was rated deemed to be very stable and as such discharge to the care of her GP. Physical Examination Findings include: Height: 157 cm, Weight: 56kg, BMI: 22.7, Pulse Rate: 70 BPM, Respiratory Rate: 26/minute, and Blood Pressure: 120/80 mmHg Skin: Pale, cold clamming extremities HEENT: Nasal flaring Lung: Use of accessory muscle of respiration, diminish breath sounds (both lungs), presence of thick and yellowish sputum One must consider other possible differential diagnosis, including: Asthma: Commonly mistaken with COPD; however, following characteristic of asthma must be noted so that management for COPD is easy: (1) generally, onset of asthma occurs earlier in life than COPD, (2) varied symptoms which disappears in between attacks, (3) presence of familiar history of asthma, (4) commonly accompanied with allergy, rhinitis, and eczema, and (5) essentially reversible airflow limitation (Leader, 2011; Price, et al., 2011). Congestive Heart Failure: COPD and CHF basically share the same characteristic symptoms; however, fine crackles at both lung bases through auscultation, dilatation of heart muscle, pulmonary oedema on CXR, and volume restriction on pulmonary function testing are unique features of CHF (Leader, 2011; Price, et al., 2011). Bronchiectasis: Tenacious, purulent sputum, bouts of recurrent bacterial infections, coarse crackles, dilatation of bronchial tubes and walls of the bronchus on x-ray, and clubbing of the fingers are noted in patients with bronchiectasis (Leader, 2011; Price, et al., 2011). Tuberculosis: Occurs at an early stage and CXR shows air spaces filled with pulmonary infiltrate and nodular lesion (Leader, 2011). Obliterative Bronchiolitis: Generally occurs at a younger age even if patient is non smoker (Leader, 2011; Price, et al., 2011). Diffuse Panbronchiolitis: Primarily occurs among males, who are non-smoker, patients with long term sinusitis, and hyperinflated lungs visible in chest x-ray and CTscan (Leader, 2011; Price, et al., 2011). Current Non-pharmacological and Pharmacological Management of COPD: GOLD (2011) current guidelines set for nonpharmacological management for patients suffering from chronic COPD include: Cessation from smoking: Our patient JC, and other patients, are encouraged by health care providers to stop from smoking. As mentioned previously, the natural history of COPD is greatly influenced by smoking cessation (GOLD, 2011). Counselling: Patient counselling delivered by physicians and other health care professionals even in a 3- minute period result to 5-10 percent of patients who stop from smoking compared to the self-initiated strategies (GOLD, 2011). Nicotine Replacement Therapy: Nicotine replacement therapy In the form of nicotine gum, inhaler, nasal spray, transdermal patch, sublingual tablet or lozenges increases long term abstinence rates from smoking and is reported to be more significantly effective compared to the placebo (GOLD, 2011). Smoking Prevention: A 50 percent reduction rate of lung function is observed among COPD patients who abstained from smoking. Smoking is the only known effective intervention in modifying COPD (Sutherland and Cherniack, 2004). Work with officials in the government to pass legislation to establish schools, facilities in the public, and work environments that are smoke-free and encourage patients to keep homes as smoke free as possible. This tobacco control policies and programs must be comprehensive with clear, consistent, and repeated messages about non-smoking (GOLD, 2011). Occupational Exposure: This is achieved through surveillance and early detection by eliminations or reduction of exposure to various substances present in the workplace (GOLD, 2011). Indoor and Outdoor Air Pollution: Measures in reduction or avoidance of burning biomass for cooking and heating in dwellings that are poorly ventilated must be implemented (GOLD, 2011). Physical Activity: Regular physical activity must be encouraged in all COPD patients since being physically active is beneficial to them. This theory is born out in our patient JC in her regular walks with her dog. Pharmacologic Therapies for Stable COPD based from GOLD (2011) guidelines are the following: Bronchodilators: To prevent or reduce symptoms, bronchodilators are prescribed on a regular or on as needed basis to provide symptomatic management in COPD. GOLD (2011) stated it is more convenient and effective to use long – acting inhaled bronchodilators compared to short acting bronchodilators at producing maintained relief of symptoms. Inhaled Corticosteroids: With regular treatment, the symptoms, lung function, and quality of life in COPD patients with FEV1 [Accessed at 25 February 2012].   Barreiro, B., Esteban, L., Prats, E., Verdaguer, E., Dorca, J., and Manresa, F., 1992. Moraxella catarrhalis respiratory infections. European Respiratory Journal, 5(6), pages 675-679.   British Medical Journal, 2012. Interventions. [Online] Available at: [Accessed 14 February 2012].   Buist, S., 2007. Epidemiology of COPD and its Co-morbidities. [Online] Available at: http://www.pneumologiamo.it/materiale/marzo2007/09_venerdi/06.%20Buist.pdf [Accessed 16 February 2012].   CDC, 2011. Chronic Obstructive Pulmonary Disease. [Online] Available at: [Accessed 16 February 2012].   COPD International, 2011. [Online] Available at: [Accessed 16 February 2012].   GOLD, 2011. Global Initiative for Chronic Obstructive Lung Disease. [Online] Available at: Accessed [15 February 2012].   GOLD, 2012. New Global Strategy for COPD Emphasizes Diseases Effect’s on Patients. [Online] Available at: [Accessed 15 February 2012].   Kelly, C., 2008. Psychological Effects of Chronic Lung Disease. [Online] Available at: < http://www.nursingtimes.net/nursing-practice-clinical-research/psychological-effects-of-chronic-lung-disease/1940860.article> [Accessed 17 February 2012]. Leader, D., 2011. Differential Diagnosis of COPD. [Online] Available at: [Accessed 14 February 2012].   Mannino, D., 2001. Chronic Obstructive and Pulmonary Disease: Epidemiology and Evaluation. [Online] Available at: [Accessed 14 February 2012].   MayoClinic, 2011. COPD. [Online] Available at: [Accessed 16 February 2012]. Mehuys, E., Boussery, K., Adriaens, E., Bortel, L., Bolle, L., Van Tongelen, I., Remon, J., and Brusselle, G., 2010. COPD Management in Primary Care: An Observational, Community Pharmacy-based Study. The Annals of Pharmacotherapy, 44(2): 257-266. Narsavage, G., 2005. Statement on Home Care for Patients with Respiratory Disorders. American Journal of Respiratory and Critical Care Medicine, 171(12): 1443-1464.   National Institute for Health and Clinical Excellence, NICE, 2010. Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. [Online] Available at: [Accessed 15 February 2012].   Patient.co.uk., 2012. Chronic Obstructive Pulmonary Disease. [Online] Available at: < http://www.patient.co.uk/health/Chronic-Obstructive-Pulmonary-Disease.htm> [Accessed 14 February 2012].   Price, D., Freeman, D., Cleland, J., Kaplan, A., and Cerasoli, F., 2011. Early Diagnosis and Earlier Treatment of COPD in Primary Care. Primary Care Respiratory Journal, 20(1): 15-22. Raherison, C., and Girodet, P., 2009. Epidemiology of COPD. European Respiratory Review, 18(114), 213-221. Respiratory Health Network, 2008. Chronic Obstructive Pulmonary Disease Model of Care. [Online] Available at: [Accessed 17 February 2012]. Sharma, S., 2012. Chronic Obstructive Pulmonary Disease. [Online] Available at: < http://www.emedicinehealth.com/chronic_obstructive_pulmonary_disease_copd/article_em.htm> [Accessed 13 February 2012]. Sutherland, R., and Cherniack, R., 2004. Management of Chronic Obstructive Pulmonary Disease. The New England Journal of Medicine, 350(2004): 3689-3697. Viegi, G., Scognamiglio, A., Baldacci, S., Pistelli, F., and Carrozzi, L., 2001. Epidemiology of Chronic Obstructive Pulmonary Disease (COPD). International Journal of Thoracic Medicine, 68(1), page 16. Viegi, G., Pistelli, F., Sherrill, D., Maio, S., Baldacci, S., and Carrozzi, L., 2007. Definition, Epidemiology, and Natural History of COPD. European Respiratory Journal, 30(5), pp. 993-1013. WebMD, 2010. Arterial Blood Gasses. [Online] Available at: [Accessed 25 February 2012].   World Health Organization, 2012. Chronic Obstructive Pulmonary Disease. [Online] Available at: [Accessed 16 February 2012].     Appendix 1: Computation of Number of Pack Years: Number of Cigarettes per day x number of years smoking = Pack years   Appendix 2: Past History of Exacerbations and Treatment of JC: August 23, 2010 – Amoxicillin 500 mg 3x a day for 21 days October 9, 2008 – Amoxicillin 500 mg 3x day for 21 days and Prednisolon 30 mg once daily for 30 days April 20, 2008 – Cefaclor MR 359 mg 2x a day for 14 days March 25, 2008 - Amoxicillin 500 mg 3x day for 21 days and Prednisolon 30 mg once daily for 30 days March 25, 2007 – Amoxicillin 500 mg 3x a day for 21 days October 8, 2007 – Amoxicillin 500 mg 3x day for 21 days September 5, 2007 - Amoxicillin 500 mg 3x day for 21 days and Prednisolon 30 mg once daily for 30 days Appendix 3: Spirometry Result     Appendix 4: Spirometry Result Appendix 5: What is Nicotine Replacement Therapy (NRT)? Nicotine replacement Therapy is a substitute of smoking where nicotine gets into the bloodstream. These include nicotine gums, patches, inhalers, tablets, lozenges, and sprays (Patient.co,uk).   Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Patient Presentation with COPD Essay Example | Topics and Well Written Essays - 3000 words”, n.d.)
Retrieved from https://studentshare.org/nursing/1395156-patient-presentation-with-copd
(Patient Presentation With COPD Essay Example | Topics and Well Written Essays - 3000 Words)
https://studentshare.org/nursing/1395156-patient-presentation-with-copd.
“Patient Presentation With COPD Essay Example | Topics and Well Written Essays - 3000 Words”, n.d. https://studentshare.org/nursing/1395156-patient-presentation-with-copd.
  • Cited: 0 times

CHECK THESE SAMPLES OF Patient Presentation with COPD

The Importance of a Sales Presentation

Sales presentation Report Introduction: Sales presentation is very crucial to almost any business.... Thus, sales presentations have seen various improvements and different styles of prospecting, presentation and closing have been mixed up to provide a strong selling proposition.... As illustrated in the case, being SMART about the objective of the sales call is also key to making a successful sales presentation.... Product: Major Oil, Inc Heating Oil: Supply and Service Prospecting Method: Cold Calling Prospect Company Description and Sales Call: The sales presentation will be a follow-up for a previous phone call that initially introduced the product, company and has set a meeting for formally presenting the products and services of Major Oil Inc and probably closing the deal....
10 Pages (2500 words) Speech or Presentation

Self-Regulatory Dysfunctions in Personality Disorders

From the case study, it is evident that the use of drugs played a role in worsening the patient's conditions.... The tool is used in theoretical counseling practices to enhance the relationship between the patient and the psychologist.... The tool provides the councilor with nine personality styles that can be used then dealing with a patient.... The use of activities that Jeremy responds to can be used in providing healthcare to the patient....
2 Pages (500 words) PowerPoint Presentation

Research Article Presentation

The paper "Research Article presentation" describes a critical opinion on the research which is of relevance to the practice of nursing since it deices ways of effective patient management.... Additionally, the research uses graphical presentation of its finding....
5 Pages (1250 words) Speech or Presentation

Conflict Scenario PowerPoint Presentation

The template given to the receptionist by the doctor could be a standard template but the template given by the scheduler may not be the standard one and so the scheduler gave a patient an appointment that does not exist.... Typically, entry-level nursing education programs provide some basic exposure to general and basic breast cancer nursing, but little direct experience in patient care and scheduling process should be offered.... Academic programs in patient care nursing are generally restricted to graduate advanced practice programs for clinical nurse specialists or nurse practitioners....
5 Pages (1250 words) PowerPoint Presentation

Photographer presentation- Martin Parr

The presence of Parr in the field of photography makes it large and entertaining since his experience has contributed to the initiative of collecting, and editing of books and exhibition.... His passion for documentary photography has never ended.... The images are always provoking… There are many things that motivate individuals in Martin Purrs work, which are always source of attraction to people. Since his teenage, he had a passion of becoming a documentary photographer....
4 Pages (1000 words) PowerPoint Presentation

Managing Students Time

It is essential that you all pay attention to this helpful report presentation.... SLIDE 2(MAJOR TOPICS IN TIME MANAGEMENT)I am going to narrow down to three main topics in my presentation of managing students time.... onclusionIt is my hope that you are not the same as you were before this presentation.... YOU WILL MAKE IT AND I BELIEVE THE STUDENTS AND PROFESSOR WILL LOVE YOUR presentation!...
4 Pages (1000 words) PowerPoint Presentation

Role of the Nurse to manage a patient with Myocardial Infarction

A nurse should clearly Role of a Nurse to Manage a Patient with Myocardial Infarction: This presentation seeks to scrutinize the role played by a nurse in providing care to a patient with myocardial infarction (MI) on myriad levels.... First, there should be careful assessment of all symptoms displayed by an MI patient including his/her physical condition.... First, there should be careful assessment of all symptoms displayed by an MI patient including his/her physical condition....
2 Pages (500 words) Speech or Presentation

Imaging Informatics Presentation

The paper "Imaging Informatics presentation" discusses that we recommended the Agfa IMPAX 6 over the Fuji Synapse because of its numerous and extra features (such as in print management, storage, syntax transfer, and so on) that greatly improve the efficiency of work.... These include such things as the presence of advanced/ useful features, maintenance/ replacement costs, costs of operations and the convenience/ ease of use, and so on, as we will see in the consequent sections of this presentation- The Agfa boasts over 20 years of existence and successful management and is regarded as the benchmark of a complete integrated system and the number one choice for most healthcare centres (Agfa Healthcare, 2012)- Along the same vein, the Agfa IMPAX 6 offers integration of the teaching files into the PACS (Agfa Healthcare, 2010) whereas the Fuji Synapse, which has no separate components for teaching documents, uses the feature of the AON to realise this function (Fujifilm, 2013)- According to the Agfa (2005) and the Fujifilm (2012), both the Agfa IMPAX 6 and the Synapse have storage for computed radiography, CT images, retired and new ultrasound multi-frame images, MR images, retired and new nuclear medicine images, retired and new ultrasound images, secondary capture images, x-ray angiographic images, x-ray radio fluoroscopic images, retired x-ray angiographic bi-plane images, digital x-ray images, digital mammography x-rays, digital intra-oral x-ray images, positron emission tomography images, visible light endoscopic/ microscopic/ photographic/ slide coordinates microscopic images, basic texts, greyscale and colour softcopy, radiation therapy dose/ structure set/ beam treatment record/ plan/ brachy treatment/ image and radiation therapy treatment summary record...
5 Pages (1250 words) PowerPoint Presentation
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us